Provectus Biopharmaceuticals PVCT
OTC PVCT
$0.05 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Provectus Biopharmaceuticals (PVCT) Selling, General & Administrative (2010 - 2026)

Updated

Provectus Biopharmaceuticals' Selling, General & Administrative was $807,548 in Q2 2026, down 17.4% from $977,373 a year earlier.

Analysis

Provectus Biopharmaceuticals (PVCT) Selling, General & Administrative (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Provectus Biopharmaceuticals' Selling, General & Administrative was $3.57 million through Jun 30, 2026, down 18.1% year-over-year; for FY2025, it was $3.73 million, up 20.5% from FY2024.

  • Selling, General & Administrative shows a five-year compound annual growth rate of 11.7% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $3.1 million in FY2024 (+81.2%), $1.71 million in FY2023 (-15.7%), $2.03 million in FY2022 (-1.8%) and $2.06 million in FY2021 (-4.0%).
  • The Q2 2026 figure marks the lowest quarterly Selling, General & Administrative since Q3 2024.
  • Compared with a year earlier, Selling, General & Administrative was higher in five of the last seven quarters, with growth averaging 173.8%.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q1 2025 (growth of 661.0%); the worst was Q1 2024 (a decline of 70.4%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,142.38 Bn 1,110.97 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 635.12 Bn 554.98 Bn 17.30 Bn 6.29 Bn
3 AbbVie 500.65 Bn 473.76 Bn 12.70 Bn 3.63 Bn
4 Merck 355.26 Bn 309.64 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 300.41 Bn 264.40 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 263.79 Bn 237.48 Bn 12.86 Bn 5.65 Bn
7 Amgen 238.16 Bn 193.56 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 1.92 Bn
9 Pfizer 170.34 Bn 116.99 Bn 10.94 Bn 3.41 Bn
10 Provectus Biopharmaceuticals 21.01 Mn 19.10 Mn - 807,548.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 807,548.00
Dec 31, 2025 852,061.00
Sep 30, 2025 929,746.00
Jun 30, 2025 977,373.00
Mar 31, 2025 987,759.00
Dec 31, 2024 1.74 Mn
Sep 30, 2024 651,486.00
Jun 30, 2024 576,918.00
Mar 31, 2024 129,802.00
Dec 31, 2023 309,955.00
Sep 30, 2023 433,089.00
Jun 30, 2023 527,831.00
Mar 31, 2023 438,845.00
Dec 31, 2022 527,350.00
Sep 30, 2022 400,689.00
Jun 30, 2022 583,042.00
Mar 31, 2022 516,547.00
Dec 31, 2021 480,749.00
Sep 30, 2021 438,578.00
Jun 30, 2021 619,038.00
API Access

Provectus Biopharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PVCT&period=max&api_key=YOUR_API_KEY